↓ Skip to main content

Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer

Overview of attention for article published in Frontiers in Pharmacology, April 2024
Altmetric Badge

Mentioned by

reddit
1 Redditor
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
Published in
Frontiers in Pharmacology, April 2024
DOI 10.3389/fphar.2024.1383580
Pubmed ID
Authors

Zhiyuan Yao, Peng Song, Wenjie Jiao

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2024.
All research outputs
#23,158,710
of 25,813,008 outputs
Outputs from Frontiers in Pharmacology
#12,558
of 20,019 outputs
Outputs of similar age
#172,393
of 217,137 outputs
Outputs of similar age from Frontiers in Pharmacology
#100
of 305 outputs
Altmetric has tracked 25,813,008 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,019 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 217,137 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 305 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.